title: Single-dose inhaled laninamivir: registered in Japan and its potential role in control of influenza epidemics.
authors.forename: Satoko
authors.initials: S
authors.lastname: Sunagawa
authors.forename: Futoshi
authors.initials: F
authors.lastname: Higa
authors.forename: Haley L
authors.initials: HL
authors.lastname: Cash
authors.forename: Masao
authors.initials: M
authors.lastname: Tateyama
authors.forename: Tsukasa
authors.initials: T
authors.lastname: Uno
authors.forename: Jiro
authors.initials: J
authors.lastname: Fujita
mesh_terms: D000280:Administration, Inhalation; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D058872:Epidemics / Q000517:prevention & control*; D006146:Guanidines; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control*; D007564:Japan / Q000453:epidemiology; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D011714:Pyrans; D012794:Sialic Acids; D053243:Zanamivir / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; C546918:laninamivir; D009439:Neuraminidase; D053243:Zanamivir